Condensed Consolidating Financial Information Balance Sheet | Condensed Consolidating Financial Information as of March 31, 2016 Westlake Chemical Corporation 100% Owned Guarantor Subsidiaries OpCo (Less Than 100% Owned Guarantor Subsidiary) Non- Guarantor Subsidiaries Eliminations Consolidated Balance Sheet Current assets Cash and cash equivalents $ 263,150 $ 1,164 $ 170,755 $ 179,907 $ — $ 614,976 Marketable securities 525,008 — — — — 525,008 Accounts receivable, net 11,705 2,205,593 62,109 133,547 (1,863,917 ) 549,037 Inventories — 363,470 2,590 112,596 — 478,656 Prepaid expenses and other current assets 2,373 16,525 157 8,605 (3,603 ) 24,057 Total current assets 802,236 2,586,752 235,611 434,655 (1,867,520 ) 2,191,734 Property, plant and equipment, net — 1,588,966 1,096,354 429,501 — 3,114,821 Equity investments 5,154,970 1,218,592 — 472,217 (6,836,348 ) 9,431 Other assets, net 46,836 499,714 44,191 133,641 (315,967 ) 408,415 Total assets $ 6,004,042 $ 5,894,024 $ 1,376,156 $ 1,470,014 $ (9,019,835 ) $ 5,724,401 Current liabilities Accounts and notes payable $ 1,834,419 $ 138,467 $ 36,118 $ 87,489 $ (1,839,109 ) $ 257,384 Accrued liabilities 15,686 138,401 34,991 88,110 (28,411 ) 248,777 Total current liabilities 1,850,105 276,868 71,109 175,599 (1,867,520 ) 506,161 Long-term debt 747,411 10,889 308,184 — (308,184 ) 758,300 Deferred income taxes — 565,865 1,571 50,099 (7,783 ) 609,752 Other liabilities — 43,015 — 102,771 — 145,786 Total liabilities 2,597,516 896,637 380,864 328,469 (2,183,487 ) 2,019,999 Total Westlake Chemical Corporation stockholders' equity 3,406,526 4,997,387 995,292 843,669 (6,836,348 ) 3,406,526 Noncontrolling interests — — — 297,876 — 297,876 Total equity 3,406,526 4,997,387 995,292 1,141,545 (6,836,348 ) 3,704,402 Total liabilities and equity $ 6,004,042 $ 5,894,024 $ 1,376,156 $ 1,470,014 $ (9,019,835 ) $ 5,724,401 Condensed Consolidating Financial Information as of December 31, 2015 Westlake Chemical Corporation 100% Owned Guarantor Subsidiaries OpCo (Less Than 100% Owned Guarantor Subsidiary) Non-Guarantor Subsidiaries Eliminations Consolidated Balance Sheet Current assets Cash and cash equivalents $ 303,131 $ 6,828 $ 163,430 $ 189,136 $ — $ 662,525 Marketable securities 520,144 — — — — 520,144 Accounts receivable, net 10,943 2,183,276 51,582 113,321 (1,850,590 ) 508,532 Inventories — 326,588 3,879 103,593 — 434,060 Prepaid expenses and other current assets 2,201 12,166 267 2,734 (2,879 ) 14,489 Deferred income taxes 702 32,787 — 1,950 — 35,439 Total current assets 837,121 2,561,645 219,158 410,734 (1,853,469 ) 2,175,189 Property, plant and equipment, net — 1,567,897 1,020,469 415,701 — 3,004,067 Equity investments 4,991,167 1,207,679 — 469,915 (6,659,553 ) 9,208 Other assets, net 11,929 450,428 44,157 129,539 (255,232 ) 380,821 Total assets $ 5,840,217 $ 5,787,649 $ 1,283,784 $ 1,425,889 $ (8,768,254 ) $ 5,569,285 Current liabilities Accounts payable $ 1,817,963 $ 121,820 $ 33,901 $ 87,510 $ (1,825,865 ) $ 235,329 Accrued liabilities 9,117 195,785 21,873 88,142 (27,604 ) 287,313 Total current liabilities 1,827,080 317,605 55,774 175,652 (1,853,469 ) 522,642 Long-term debt 747,259 10,889 248,665 — (248,665 ) 758,148 Deferred income taxes — 532,837 1,392 47,941 (6,567 ) 575,603 Other liabilities — 49,334 — 101,627 — 150,961 Total liabilities 2,574,339 910,665 305,831 325,220 (2,108,701 ) 2,007,354 Total Westlake Chemical Corporation stockholders' equity 3,265,878 4,876,984 977,953 804,616 (6,659,553 ) 3,265,878 Noncontrolling interests — — — 296,053 — 296,053 Total equity 3,265,878 4,876,984 977,953 1,100,669 (6,659,553 ) 3,561,931 Total liabilities and equity $ 5,840,217 $ 5,787,649 $ 1,283,784 $ 1,425,889 $ (8,768,254 ) $ 5,569,285 |
Condensed Consolidating Financial Information Statement Of Operations | Condensed Consolidating Financial Information for the Three Months Ended March 31, 2016 Westlake Chemical Corporation 100% Owned Guarantor Subsidiaries OpCo (Less Than 100% Owned Guarantor Subsidiary) Non- Guarantor Subsidiaries Eliminations Consolidated Statement of Operations Net sales $ — $ 784,060 $ 252,604 $ 262,915 $ (324,392 ) $ 975,187 Cost of sales — 665,462 142,190 230,874 (318,924 ) 719,602 Gross profit — 118,598 110,414 32,041 (5,468 ) 255,585 Selling, general and administrative expenses 607 40,628 5,278 12,264 (5,468 ) 53,309 (Loss) income from operations (607 ) 77,970 105,136 19,777 — 202,276 Interest expense (10,411 ) (3 ) (251 ) (78 ) 4,058 (6,685 ) Other income (expense), net 1,815 6,445 84 (1,641 ) (4,058 ) 2,645 (Loss) income before income taxes (9,203 ) 84,412 104,969 18,058 — 198,236 (Benefit from) provision for income taxes (3,219 ) 66,580 399 5,540 — 69,300 Equity in net income of subsidiaries 129,112 90,687 — 13,883 (233,682 ) — Net income 123,128 108,519 104,570 26,401 (233,682 ) 128,936 Net income attributable to noncontrolling interests — — — 5,808 — 5,808 Net income attributable to Westlake Chemical Corporation $ 123,128 $ 108,519 $ 104,570 $ 20,593 $ (233,682 ) $ 123,128 Comprehensive income attributable to Westlake Chemical Corporation $ 161,757 $ 120,405 $ 104,570 $ 43,398 $ (268,373 ) $ 161,757 Condensed Consolidating Financial Information for the Three Months Ended March 31, 2015 Westlake Chemical Corporation 100% Owned Guarantor Subsidiaries OpCo (Less Than 100% Owned Guarantor Subsidiary) Non- Guarantor Subsidiaries Eliminations Consolidated Statement of Operations Net sales $ — $ 903,492 $ 258,391 $ 245,643 $ (303,995 ) $ 1,103,531 Cost of sales — 727,399 162,164 228,269 (298,847 ) 818,985 Gross profit — 176,093 96,227 17,374 (5,148 ) 284,546 Selling, general and administrative expenses 413 43,684 5,046 11,271 (5,148 ) 55,266 (Loss) income from operations (413 ) 132,409 91,181 6,103 — 229,280 Interest expense (10,752 ) (1 ) (1,376 ) (42 ) 2,580 (9,591 ) Other income, net 6,612 2,827 5 2,232 (2,580 ) 9,096 (Loss) income before income taxes (4,553 ) 135,235 89,810 8,293 — 228,785 (Benefit from) provision for income taxes (1,578 ) 77,999 467 1,490 — 78,378 Equity in net income of subsidiaries 149,317 79,891 — 9,452 (238,660 ) — Net income 146,342 137,127 89,343 16,255 (238,660 ) 150,407 Net income attributable to noncontrolling interests — — — 4,065 — 4,065 Net income attributable to Westlake Chemical Corporation $ 146,342 $ 137,127 $ 89,343 $ 12,190 $ (238,660 ) $ 146,342 Comprehensive income (loss) attributable to Westlake Chemical Corporation $ 88,113 $ 137,365 $ 89,343 $ (47,319 ) $ (179,389 ) $ 88,113 |
Condensed Consolidating Financial Information Statement Of Cash Flows | Condensed Consolidating Financial Information as of March 31, 2016 Westlake Chemical Corporation 100% Owned Guarantor Subsidiaries OpCo (Less Than 100% Owned Guarantor Subsidiary) Non- Guarantor Subsidiaries Eliminations Consolidated Balance Sheet Current assets Cash and cash equivalents $ 263,150 $ 1,164 $ 170,755 $ 179,907 $ — $ 614,976 Marketable securities 525,008 — — — — 525,008 Accounts receivable, net 11,705 2,205,593 62,109 133,547 (1,863,917 ) 549,037 Inventories — 363,470 2,590 112,596 — 478,656 Prepaid expenses and other current assets 2,373 16,525 157 8,605 (3,603 ) 24,057 Total current assets 802,236 2,586,752 235,611 434,655 (1,867,520 ) 2,191,734 Property, plant and equipment, net — 1,588,966 1,096,354 429,501 — 3,114,821 Equity investments 5,154,970 1,218,592 — 472,217 (6,836,348 ) 9,431 Other assets, net 46,836 499,714 44,191 133,641 (315,967 ) 408,415 Total assets $ 6,004,042 $ 5,894,024 $ 1,376,156 $ 1,470,014 $ (9,019,835 ) $ 5,724,401 Current liabilities Accounts and notes payable $ 1,834,419 $ 138,467 $ 36,118 $ 87,489 $ (1,839,109 ) $ 257,384 Accrued liabilities 15,686 138,401 34,991 88,110 (28,411 ) 248,777 Total current liabilities 1,850,105 276,868 71,109 175,599 (1,867,520 ) 506,161 Long-term debt 747,411 10,889 308,184 — (308,184 ) 758,300 Deferred income taxes — 565,865 1,571 50,099 (7,783 ) 609,752 Other liabilities — 43,015 — 102,771 — 145,786 Total liabilities 2,597,516 896,637 380,864 328,469 (2,183,487 ) 2,019,999 Total Westlake Chemical Corporation stockholders' equity 3,406,526 4,997,387 995,292 843,669 (6,836,348 ) 3,406,526 Noncontrolling interests — — — 297,876 — 297,876 Total equity 3,406,526 4,997,387 995,292 1,141,545 (6,836,348 ) 3,704,402 Total liabilities and equity $ 6,004,042 $ 5,894,024 $ 1,376,156 $ 1,470,014 $ (9,019,835 ) $ 5,724,401 Condensed Consolidating Financial Information as of December 31, 2015 Westlake Chemical Corporation 100% Owned Guarantor Subsidiaries OpCo (Less Than 100% Owned Guarantor Subsidiary) Non-Guarantor Subsidiaries Eliminations Consolidated Balance Sheet Current assets Cash and cash equivalents $ 303,131 $ 6,828 $ 163,430 $ 189,136 $ — $ 662,525 Marketable securities 520,144 — — — — 520,144 Accounts receivable, net 10,943 2,183,276 51,582 113,321 (1,850,590 ) 508,532 Inventories — 326,588 3,879 103,593 — 434,060 Prepaid expenses and other current assets 2,201 12,166 267 2,734 (2,879 ) 14,489 Deferred income taxes 702 32,787 — 1,950 — 35,439 Total current assets 837,121 2,561,645 219,158 410,734 (1,853,469 ) 2,175,189 Property, plant and equipment, net — 1,567,897 1,020,469 415,701 — 3,004,067 Equity investments 4,991,167 1,207,679 — 469,915 (6,659,553 ) 9,208 Other assets, net 11,929 450,428 44,157 129,539 (255,232 ) 380,821 Total assets $ 5,840,217 $ 5,787,649 $ 1,283,784 $ 1,425,889 $ (8,768,254 ) $ 5,569,285 Current liabilities Accounts payable $ 1,817,963 $ 121,820 $ 33,901 $ 87,510 $ (1,825,865 ) $ 235,329 Accrued liabilities 9,117 195,785 21,873 88,142 (27,604 ) 287,313 Total current liabilities 1,827,080 317,605 55,774 175,652 (1,853,469 ) 522,642 Long-term debt 747,259 10,889 248,665 — (248,665 ) 758,148 Deferred income taxes — 532,837 1,392 47,941 (6,567 ) 575,603 Other liabilities — 49,334 — 101,627 — 150,961 Total liabilities 2,574,339 910,665 305,831 325,220 (2,108,701 ) 2,007,354 Total Westlake Chemical Corporation stockholders' equity 3,265,878 4,876,984 977,953 804,616 (6,659,553 ) 3,265,878 Noncontrolling interests — — — 296,053 — 296,053 Total equity 3,265,878 4,876,984 977,953 1,100,669 (6,659,553 ) 3,561,931 Total liabilities and equity $ 5,840,217 $ 5,787,649 $ 1,283,784 $ 1,425,889 $ (8,768,254 ) $ 5,569,285 Condensed Consolidating Financial Information for the Three Months Ended March 31, 2016 Westlake Chemical Corporation 100% Owned Guarantor Subsidiaries OpCo (Less Than 100% Owned Guarantor Subsidiary) Non- Guarantor Subsidiaries Eliminations Consolidated Statement of Operations Net sales $ — $ 784,060 $ 252,604 $ 262,915 $ (324,392 ) $ 975,187 Cost of sales — 665,462 142,190 230,874 (318,924 ) 719,602 Gross profit — 118,598 110,414 32,041 (5,468 ) 255,585 Selling, general and administrative expenses 607 40,628 5,278 12,264 (5,468 ) 53,309 (Loss) income from operations (607 ) 77,970 105,136 19,777 — 202,276 Interest expense (10,411 ) (3 ) (251 ) (78 ) 4,058 (6,685 ) Other income (expense), net 1,815 6,445 84 (1,641 ) (4,058 ) 2,645 (Loss) income before income taxes (9,203 ) 84,412 104,969 18,058 — 198,236 (Benefit from) provision for income taxes (3,219 ) 66,580 399 5,540 — 69,300 Equity in net income of subsidiaries 129,112 90,687 — 13,883 (233,682 ) — Net income 123,128 108,519 104,570 26,401 (233,682 ) 128,936 Net income attributable to noncontrolling interests — — — 5,808 — 5,808 Net income attributable to Westlake Chemical Corporation $ 123,128 $ 108,519 $ 104,570 $ 20,593 $ (233,682 ) $ 123,128 Comprehensive income attributable to Westlake Chemical Corporation $ 161,757 $ 120,405 $ 104,570 $ 43,398 $ (268,373 ) $ 161,757 Condensed Consolidating Financial Information for the Three Months Ended March 31, 2015 Westlake Chemical Corporation 100% Owned Guarantor Subsidiaries OpCo (Less Than 100% Owned Guarantor Subsidiary) Non- Guarantor Subsidiaries Eliminations Consolidated Statement of Operations Net sales $ — $ 903,492 $ 258,391 $ 245,643 $ (303,995 ) $ 1,103,531 Cost of sales — 727,399 162,164 228,269 (298,847 ) 818,985 Gross profit — 176,093 96,227 17,374 (5,148 ) 284,546 Selling, general and administrative expenses 413 43,684 5,046 11,271 (5,148 ) 55,266 (Loss) income from operations (413 ) 132,409 91,181 6,103 — 229,280 Interest expense (10,752 ) (1 ) (1,376 ) (42 ) 2,580 (9,591 ) Other income, net 6,612 2,827 5 2,232 (2,580 ) 9,096 (Loss) income before income taxes (4,553 ) 135,235 89,810 8,293 — 228,785 (Benefit from) provision for income taxes (1,578 ) 77,999 467 1,490 — 78,378 Equity in net income of subsidiaries 149,317 79,891 — 9,452 (238,660 ) — Net income 146,342 137,127 89,343 16,255 (238,660 ) 150,407 Net income attributable to noncontrolling interests — — — 4,065 — 4,065 Net income attributable to Westlake Chemical Corporation $ 146,342 $ 137,127 $ 89,343 $ 12,190 $ (238,660 ) $ 146,342 Comprehensive income (loss) attributable to Westlake Chemical Corporation $ 88,113 $ 137,365 $ 89,343 $ (47,319 ) $ (179,389 ) $ 88,113 Condensed Consolidating Financial Information for the Three Months Ended March 31, 2016 Westlake Chemical Corporation 100% Owned Guarantor Subsidiaries OpCo (Less Than 100% Owned Guarantor Subsidiary) Non- Guarantor Subsidiaries Eliminations Consolidated Statement of Cash Flows Cash flows from operating activities Net income $ 123,128 $ 108,519 $ 104,570 $ 26,401 $ (233,682 ) $ 128,936 Adjustments to reconcile net income to net cash provided by operating activities Depreciation and amortization 220 35,383 20,396 9,935 — 65,934 Deferred income taxes (2,724 ) 59,139 179 2,043 — 58,637 Net changes in working capital and other (120,565 ) (188,331 ) (11,115 ) (38,243 ) 233,682 (124,572 ) Net cash provided by operating activities 59 14,710 114,030 136 — 128,935 Cash flows from investing activities Additions to property, plant and equipment — (50,568 ) (79,091 ) (6,669 ) — (136,328 ) Proceeds from disposition of assets — 6 98 — — 104 Proceeds from sales and maturities of securities 26,859 — — — — 26,859 Purchase of securities (29,045 ) (7,592 ) — — — (36,637 ) Settlements of derivative instruments — (1,219 ) — — — (1,219 ) Net cash used for investing activities (2,186 ) (59,373 ) (78,993 ) (6,669 ) — (147,221 ) Cash flows from financing activities Intercompany financing (13,763 ) (41,000 ) 59,519 (4,756 ) — — Dividends paid (23,700 ) — — — — (23,700 ) Distributions paid — 79,999 (87,231 ) 3,247 — (3,985 ) Proceeds from exercise of stock options 22 — — — — 22 Proceeds from issuance of notes payable — — — 2,050 — 2,050 Repayment of notes payable — — — (7,095 ) — (7,095 ) Repurchase of common stock for treasury (679 ) — — — — (679 ) Windfall tax benefits from share-based payment arrangements 266 — — — — 266 Net cash (used for) provided by financing activities (37,854 ) 38,999 (27,712 ) (6,554 ) — (33,121 ) Effect of exchange rate changes on cash and cash equivalents — — — 3,858 — 3,858 Net (decrease) increase in cash and cash equivalents (39,981 ) (5,664 ) 7,325 (9,229 ) — (47,549 ) Cash and cash equivalents at beginning of period 303,131 6,828 163,430 189,136 — 662,525 Cash and cash equivalents at end of period $ 263,150 $ 1,164 $ 170,755 $ 179,907 $ — $ 614,976 Condensed Consolidating Financial Information for the Three Months Ended March 31, 2015 Westlake Chemical Corporation 100% Owned Guarantor Subsidiaries OpCo (Less Than 100% Owned Guarantor Subsidiary) Non- Guarantor Subsidiaries Eliminations Consolidated Statement of Cash Flows Cash flows from operating activities Net income $ 146,342 $ 137,127 $ 89,343 $ 16,255 $ (238,660 ) $ 150,407 Adjustments to reconcile net income to net cash (used for) provided by operating activities Depreciation and amortization 501 29,592 19,803 9,246 — 59,142 Deferred income taxes (124 ) 6,431 54 (1,030 ) — 5,331 Net changes in working capital and other (151,572 ) (114,779 ) 6,973 (3,606 ) 238,660 (24,324 ) Net cash (used for) provided by operating activities (4,853 ) 58,371 116,173 20,865 — 190,556 Cash flows from investing activities Additions to property, plant and equipment — (47,385 ) (39,540 ) (8,897 ) — (95,822 ) Settlements of derivative instruments — (833 ) — — — (833 ) Net cash used for investing activities — (48,218 ) (39,540 ) (8,897 ) — (96,655 ) Cash flows from financing activities Intercompany financing 72,634 (99,765 ) 30,191 (3,060 ) — — Dividends paid (21,964 ) — — — — (21,964 ) Distributions paid — 89,161 (95,364 ) 2,645 — (3,558 ) Proceeds from exercise of stock options 157 — — — — 157 Repurchase of common stock for treasury (2,000 ) — — — — (2,000 ) Windfall tax benefits from share-based payment arrangements 1,701 — — — — 1,701 Net cash provided by (used for) financing activities 50,528 (10,604 ) (65,173 ) (415 ) — (25,664 ) Effect of exchange rate changes on cash and cash equivalents — — — (3,189 ) — (3,189 ) Net increase (decrease) in cash and cash equivalents 45,675 (451 ) 11,460 8,364 — 65,048 Cash and cash equivalents at beginning of period 655,947 3,057 131,545 90,052 — 880,601 Cash and cash equivalents at end of period $ 701,622 $ 2,606 $ 143,005 $ 98,416 $ — $ 945,649 |